Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,672 | Dovepress* | 6,198+ | 1,347 | 7,545 | |
PubMed Central* | 474 | 218 | 692 | ||
Totals | 6,672 | 1,565 | 8,237 | ||
*Since 19 September 2018 |
View citations on PubMed Central and Google Scholar